Skip to content

OSTEODUO: what changed

BE 0867.694.296NACE 86.210, General medical practiceOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€329
2024 · €13,839-€13,510
Equity
-€17,681
2024 · -€18,010+€329
Cash
-
2024 · €1,936-€1,936
Balance sheet total
€2,399
2024 · €3,875-€1,476

Largest movements

2024 to 2025
Assets
  • Cash -€1,936

    no longer reported in 2025; in 2024 it stood at €1,936

    mainly Other debts (-€1,267) and Receivables within one year (-€1,225)

  • Receivables within one year +€1,225

    up €1,225 (+132%), from €924 to €2,149

    of which Trade receivables: +€692

  • Deferred charges and accrued income -€765

    no longer reported in 2025; in 2024 it stood at €765

Equity and liabilities
  • Other debts -€1,267

    down €1,267 (-6.4%), from €19,752 to €18,485

  • Trade debts -€539

    down €539 (-71.8%), from €750 to €212

  • Profit (loss) carried forward +€329

    up €329 (+0.7%), from -€50,449 to -€50,120

Income statement
  • Gross operating margin -€14,871

    down €14,871 (-93.9%), from €15,837 to €966

  • Taxes -€1,384

    no longer reported in 2025; in 2024 it stood at €1,384

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €13,839
Gross operating margin -€14,871
Other operating charges +€6
Financial charges -€29
Taxes +€1,384
Result 2025 €329
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€1,936
Investment €0
Financing €0
Cash 2024 €1,936
Net result for the year +€329
Receivables within one year -€1,225
Deferred charges and accrued income +€765
Trade debts -€539
Other debts -€1,267
Cash 2025 €0
brings cash intakes cash out
Every line side by side 31 lines
Line Code 2024 2025 Change %
Total assets 20/58 €3,875 €2,399 -€1,476 -38.1%
Fixed assets 21/28 €250 €250 = 0.0%
Financial fixed assets 28 €250 €250 = 0.0%
Current assets 29/58 €3,625 €2,149 -€1,476 -40.7%
Amounts receivable within one year 40/41 €924 €2,149 +€1,225 +132%
Trade receivables 40 €924 €1,617 +€692 +74.9%
Other amounts receivable 41 - €532 +€532
Cash at bank and in hand 54/58 €1,936 - -€1,936
Deferred charges and accrued income 490/1 €765 - -€765
Total equity and liabilities 10/49 €3,875 €2,399 -€1,476 -38.1%
Equity 10/15 -€18,010 -€17,681 +€329 +1.8%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €13,839 €13,839 = 0.0%
Distributable reserves 133 €13,839 €13,839 = 0.0%
Profit (loss) carried forward 14 -€50,449 -€50,120 +€329 +0.7%
Amounts payable 17/49 €21,885 €20,080 -€1,805 -8.2%
Amounts payable within one year 42/48 €21,885 €20,080 -€1,805 -8.2%
Trade debts 44 €750 €212 -€539 -71.8%
Suppliers 440/4 €750 €212 -€539 -71.8%
Taxes, remuneration and social security 45 €1,384 €1,384 = 0.0%
Taxes 450/3 €1,384 €1,384 = 0.0%
Other amounts payable 47/48 €19,752 €18,485 -€1,267 -6.4%
Other operating charges 640/8 €471 €465 -€6 -1.3%
Gross operating margin 9900 €15,837 €966 -€14,871 -93.9%
Operating profit (loss) 9901 €15,366 €500 -€14,865 -96.7%
Financial charges 65/66B €142 €172 +€29 +20.4%
Recurring financial charges 65 €142 €172 +€29 +20.4%
Profit (loss) for the period before taxes 9903 €15,223 €329 -€14,894 -97.8%
Income taxes 67/77 €1,384 - -€1,384
Profit (loss) for the period 9904 €13,839 €329 -€13,510 -97.6%
Profit (loss) for the period to be appropriated 9905 €13,839 €329 -€13,510 -97.6%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€3,634 to €8,624

Midpoint €5,713 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity -€17,681
Capitalised earnings €24,950 to €34,930
Indication €3,634 to €8,624

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
-€17,681
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
-€17,681

Capitalised earnings

net result for the year (9904)
2025
€329
2024
€13,839
2023
-€3,688
2022
€1,358
2021
-€4,624
Average result
€3,493
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€24,950 / €29,108 / €34,930

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 16 November 2026 via checked.be.